BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP‑1 cells via the Rb/E2F1 pathway in cervical carcinomaLimin Liu(Soochow University), Zhihua Liu(Southern Medical University)Oncology ReportsSeptember 24, 202110.3892/or.2021.8196Cited by 15SaveCiteExport RISWatch citationsRelated PapersEstrogen-Induced Nongenomic Calcium Signaling Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor α Production in Macrophages|PLoS ONE|2013|30